Profile
| Metric | Value |
|---|---|
| Full Name | Teladoc Health, Inc. |
| Ticker | NYSE: TDOC |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Health Information Services |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | teladochealth.com |
| Employees | 4,620 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $5.78 | |
| Price, 1D Change | -2.20% | |
| Market Cap | $1B | |
| - | ||
| PE Ratio | - | |
| Beta | 1.43 | |
| Revenue | $3B | |
| Revenue, 1Y Change | -1.26% | |
| EPS | -$5.87 | |
| EPS, 1Y Change | -338.40% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$5.87 | |
| EPS Estimate | -$0.99 | |
| EPS Est. Change | +83.10% | |
| Revenue | $2.57B | |
| Revenue Estimate | $2.52B | |
| Revenue Est. Change | -1.81% | |
| Current Price | $5.78 | |
| Price Target | - | $8.50 |
| Price Tgt. Change | - | +47.06% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.38 | -$1.34 | +2.97% | |
| -$1.19 | -$5.87 | -393.29% | |
| -$0.99 | N/A | +83.10% | |
| -$0.86 | N/A | +85.32% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.61B | $2.60B | -0.39% | |
| $2.57B | $2.57B | +0.04% | |
| $2.52B | N/A | -1.81% | |
| $2.55B | N/A | -0.82% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -45.06% | |
| Price, 3Y | -80.39% | |
| Market Cap, 1Y | -43.77% | |
| Market Cap, 3Y | -78.62% | |
| Revenue, 1Y | -1.26% | |
| Revenue, 3Y | +26.41% | |
| EPS, 1Y | -338.40% | |
| EPS, 3Y | -114.85% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $5.78 | |
| SMA 200 | $7.57 | |
| SMA 200 vs Price | +30.89% | |
| SMA 50 | $7.12 | |
| SMA 50 vs Price | +23.22% | |
| Beta | 1.43 | |
| ATR | $0.30 | |
| 14-Day RSI | 30.41 | |
| 10-Day Volatility | 47.06% | |
| 1-Year Volatility | 60.63% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $2.57B | |
| EPS | -$5.87 | |
| Gross Profit | $1.82B | |
| Gross Margin | 70.76% | |
| Operating Profit | -$208.79M | |
| Operating Margin | -8.13% | |
| Net Income | -$1.00B | |
| Net Margin | -38.97% | |
| EBITDA | -$587.01M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 1.03 | |
| Current Ratio | 1.77 | |
| Quick Ratio | 1.73 | |
| Interest Coverage | -40.74 | |
| F-Score | 4 | |
| Altman Z-Score | -5.70 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | 0.41 | |
| PB Ratio | 0.74 | |
| EV/EBITDA | 7.19 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $1.49B | |
| Cash & Equivalents | $1.30B | |
| Total Assets | $3.76B | |
| Current Assets | $1.66B | |
| Total Liabilities | $2.27B | |
| Current Liabilities | $941.54M | |
| Total Debt | $1.58B | |
| Short Term Debt | $561.06M | |
| Accounts Payable | $33.13M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $2.78B | |
| Operating Expenses | $2.03B | |
| Cost Of Goods Sold | $751.27M | |
| SG&A | $1.35B | |
| D&A | $382.84M | |
| Interest Expense | $23.80M | |
| Income Tax | $7.59M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $293.68M | |
| CFI | -$124.05M | |
| CFF | $8.31M | |
| Capex | $124.05M | |
| Free Cash Flow | $169.63M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Citigroup | → | |
| Barclays | ||
| B of A Securities | → | |
| BMO Capital | ||
| Evercore ISI Group | → | |
| Citigroup | → | |
| Evercore ISI Group | → | |
| Mizuho | ||
| Evercore ISI Group | → | |
| B of A Securities | → |
Analyst sentiment
Institutional ownership
Screeners with TDOC
FAQ
What is the ticker symbol for Teladoc Health, Inc.?
The ticker symbol for Teladoc Health, Inc. is NYSE:TDOC
Does Teladoc Health, Inc. pay dividends?
No, Teladoc Health, Inc. does not pay dividends
What sector is Teladoc Health, Inc. in?
Teladoc Health, Inc. is in the Healthcare sector
What industry is Teladoc Health, Inc. in?
Teladoc Health, Inc. is in the Health Information Services industry
What country is Teladoc Health, Inc. based in?
Teladoc Health, Inc. is headquartered in United States
When did Teladoc Health, Inc. go public?
Teladoc Health, Inc. initial public offering (IPO) was on June 30, 2015
Is Teladoc Health, Inc. in the S&P 500?
No, Teladoc Health, Inc. is not included in the S&P 500 index
Is Teladoc Health, Inc. in the NASDAQ 100?
No, Teladoc Health, Inc. is not included in the NASDAQ 100 index
Is Teladoc Health, Inc. in the Dow Jones?
No, Teladoc Health, Inc. is not included in the Dow Jones index
When was Teladoc Health, Inc. last earnings report?
Teladoc Health, Inc.'s most recent earnings report was on October 29, 2025
When does Teladoc Health, Inc. report earnings?
The next expected earnings date for Teladoc Health, Inc. is February 25, 2026
Data Sources & References
- TDOC Official Website www.teladochealth.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1477449/000147744925000120/0001477449-25-000120-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1477449/000147744925000005/0001477449-25-000005-index.htm
- TDOC Profile on Yahoo Finance finance.yahoo.com/quote/TDOC
- TDOC Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tdoc